IPRIPR2023-00478Institution Denied
Sandoz Inc.v.Acerta Pharma B.V. et al.
IPR challenge of US 10272083.
Type
IPR
Filed
Feb 3, 2023
Instituted
Aug 7, 2023
Decided
Aug 7, 2023
Patent
Application
15112968
Inventor
Ahmed Hamdy et al
Granted
Apr 30, 2019
01
Timeline
3 milestones
2023-02-03Petition filed
2023-08-07Institution
2023-08-07Terminated
02
Parties & counsel
Petitioner
Sandoz Inc.
Counsel
Wong, Jovialet al
Patent Owner
Acerta Pharma B.V. et al.
Counsel
Fisher, Stanleyet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →